SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001048750-03-000030
Filing Date
2003-02-14
Accepted
2003-02-14 15:00:18
Documents
2
Group Members
EMANUEL J. FRIEDMANERIC F. BILLINGSFRIEDMAN, BILLINGS, RAMSEY GROUP, INC.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 lynx13ga2ye.txt SC 13G/A 11306
3 JOINT FILING AGREEMENT lynx2agreement.txt EX-1 1742
  Complete submission text file 0001048750-03-000030.txt   15339
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Subject) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45862 | Film No.: 03566760
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 1001 NINETEENTH ST N ARLINGTON VA 22209
Business Address 1001 19TH STREET N ARLINGTON VA 22209 7033129500
FRIEDMAN BILLINGS RAMSEY GROUP INC (Filed by) CIK: 0001048750 (see all company filings)

IRS No.: 541837743 | State of Incorp.: VA | Fiscal Year End: 1231
SIC: 6211 Security Brokers, Dealers & Flotation Companies